Results 71 to 80 of about 166,676 (142)

Lipidomic approach for stratification of Acute Myeloid Leukemia patients [PDF]

open access: yesarXiv, 2016
The pathogenesis and progression of many tumors, including hematologic malignancies is highly dependent on enhanced lipogenesis. De novo fatty-acid synthesis permits accelerated proliferation of tumor cells by providing structural components to build the membranes.
arxiv  

Self-Supervised Multiple Instance Learning for Acute Myeloid Leukemia Classification [PDF]

open access: yesarXiv
Automated disease diagnosis using medical image analysis relies on deep learning, often requiring large labeled datasets for supervised model training. Diseases like Acute Myeloid Leukemia (AML) pose challenges due to scarce and costly annotations on a single-cell level.
arxiv  

A tumor-immune model of chronic myeloid leukemia with optimal immunotherapeutic protocols [PDF]

open access: yesarXiv
The interactions between tumor cells and the immune system play a crucial role in cancer evolution. In this study, we explore how these interactions influence cancer progression by modeling the relationships among naive T cells, effector T cells, and chronic myeloid leukemia cells. We examine the existence of equilibria, the asymptotic stability of the
arxiv  

Clinical Validation of a Real-Time Machine Learning-based System for the Detection of Acute Myeloid Leukemia by Flow Cytometry [PDF]

open access: yesarXiv
Machine-learning (ML) models in flow cytometry have the potential to reduce error rates, increase reproducibility, and boost the efficiency of clinical labs. While numerous ML models for flow cytometry data have been proposed, few studies have described the clinical deployment of such models.
arxiv  

Reverse Degree-Based Topological Indices and QSPR Analysis of Cancer Drugs [PDF]

open access: yesarXiv
A topological index of a graph $G$ is a numerical quantity that describes its topology. Reverse degree-based topological indices play an important role in finding topological descriptors. Azacitidine, Decitabine, and Guadecitabine are hypomethylating agents which are used for the treatment of patients with higher-risk myelodysplastic syndromes, acute ...
arxiv  

The road not taken: Exploring non-transplant options in De Novo philadelphia positive acute myeloid leukemia. [PDF]

open access: yesLeuk Res Rep
Sharif MI   +6 more
europepmc   +1 more source

Assessment of chromatin remodeling of acute myeloid leukemia cells treated with gilteritinib: a case report. [PDF]

open access: yesJ Med Case Rep
Mori J   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy